CITRONELLOL ALKOXYLATE SURFACTANTS

CROSS-REFERENCE TO RELATED APPLICATIONS This application is an international application claiming priority to and the benefit of U.S. Provisional Application No. 63/222,170, filed on July 15, 2021, the contents of which are hereby incorporated by reference in its entirety.

FIELD OF INVENTION

[0001] The present disclosure is directed to novel derivatives of citronellol and polycitronellol, particularly ethoxylated and propoxylated derivatives of citronellol and polycitronellol, and methods of making them, compositions comprising them, and methods for using them, particularly as surfactants.

BACKGROUND

[0002] Surfactants are a multimillion-dollar annual industry. Surfactants are generally molecules which have at least one strongly polar or ionic functional group and at least one strongly nonpolar or hydrophobic functional group, generally positioned at opposite ends of a largely linear molecule. Thus, one end of a surfactant molecule is usually hydrophilic, while the other end is hydrophobic. The unique chemical property of surfactants is their ability to dissolve in both aqueous media and nonpolar (hydrophobic) media by virtue of this amphiphilic divided structure. They find use in a variety of products, often at the junction between aqueous and hydrophobic environments, especially when they are used in soaps and detergents. Functionally, surfactants are often used as wetting agents, detergents, soaps, emulsifiers, foaming agents, and dispersants. They are also commonly used in a variety of multicomponent compositions in order to stabilize the interactions between hydrophobic and hydrophilic ingredients.

[0003] There are a variety of different classes of commercially available surfactants, most of which are derived from petrochemical feedstocks. These include anionic surfactants such as sulfates, sulfonates, phosphates, and carboxylates; cationic surfactants, such as quaternary amines; zwitterionic surfactants, such as betaines, sultaines, and amine oxides; and non-ionic surfactants, such as alkoxylates, and polyhydroxy fatty acid esters. [0004] The use of alkoxylates, i.e., poly(ethylene glycol) or poly(propylene glycol) moieties, is common in several classes of surfactants. These include alkyl phenol ethoxylates and propoxylates, such as nonylphenol ethoxylates, aliphatic alcohol ethoxylates such as fatty alcohol ethoxylates and propoxylates, such as cetyl propoxylate, fatty acid ethoxylates and propoxylates, fatty amine ethoxylates and propoxylates, monoalkanolamide ethoxylates, sorbitan ester ethoxylates, ethoxylated glucosides, and glycerol esters (such as glycerol propoxylate), as well as poly ether polymers such as poly (ethylene oxide), poly (propylene oxide) and ethylene oxide/propylene oxide copolymers.

[0005] Many alkoxylated surfactants are coming under increased scrutiny because of their toxicity, or for their lack of biodegradability resulting in environmental persistence. For example, nonylphenol ethoxylates, which were once very common in detergents, textile manufacturing and drilling mud, have been banned in Europe since 2005 due to concerns over environmental toxicity and persistence. Yet, in 2013, nonylphenol ethoxylates still accounted for almost half of global nonionic surfactant production, despite increasing calls for prohibition at the international level.

[0006] Thus, there is an urgent need for new alkoxylated surfactants, especially surfactants with improved stability, improved biodegradability, and/or improved environmental impact. It would be especially advantageous to have new surfactants sourced from renewable resources. [0007] Terpene alcohols such as citronellol are renewable resources. Citronellol may be sourced naturally from such plant species as citronella grass, or prepared semi-synthetically by hydrogenation of geraniol or nerol, themselves natural resources derived from, respectively, geranium grass, and lemongrass. Geraniol and nerol and other related terpenes can also be derived from the pyrolysis products of beta-pinene, which is widely available from numerous botanical families (e.g., cumin, hemp, hops, cannabis, cluster pine, and Clausena anisata).

[0008] Terpene alcohol derivatives include polymers and oligomers of terpene alcohols. For example, citronellol has been formed into useful oligomeric and polymeric products having the following structure: wherein n is an integer from 0 to 20 (e.g., 0-3). Dimers, trimers, and other oligomers of citronellol have been described. See, e.g., US2017/0283553, US2020/0165383, and US2020/0392287, the contents of each of which are hereby incorporated by reference in their entireties. One of the benefits of this class of polymers is the reversibility of the polymerization chemistry which creates them from citronellol. As a result, these polyether polymers are biodegradable, reverting to citronellol naturally. Alkoxylated polymers based on polycitronellol would thus also be expected to be biodegradable, providing a much more environmentally friendly and renewable-resource based

BRIEF SUMMARY OF THE INVENTION

[0009] In a first aspect, the present disclosure provides citronellol and polycitronellol alkoxylate surfactants, derived from citronellol monomer or polycitronellol oligomers and derivatives thereof. These compounds are useful in numerous types of compositions, and numerous roles. For example, these compounds may be used as wetting agents, detergents, soaps, emulsifiers, foaming agents, dispersants, buffers, preservatives, and are especially useful as ingredients in personal care compositions, cosmetic compositions, food compositions, and crop care compositions.

[00010] In a second aspect, the present disclosure provides a method of preparing such compounds.

[00011] In a third aspect, the present disclosure provides compositions and products comprising such compounds. In some embodiments, said compounds are useful in a variety of applications, including as or in cosmetics, soaps, hair care products, fragrances, sunscreens, household cleaning products (e.g., laundry detergents), plastic additives, paints, coatings, lubricants, surfactants, insecticides, and herbicides.

DETAILED DESCRIPTION OF THE INVENTION [00012] As used herein, the term “polycitronellol” refers to a polymer having the following structure, saturated or unsaturated: wherein n is an integer from 0 to 20 (e.g., 0-3). While other polymeric derivatives of citronellol may be possible (i.e., having a different structure or nature of connectivity), these are not embraced by the term “poly citronellol” as used herein. The polycitronellol polymers described herein are derived from polymerization of the alcohol groups of citronellol with the alkene groups by an alkene addition reaction. These polymers can undergo a depolymerization based on an elimination mechanism, providing alcohol and alkene products.

[00013] In a first embodiment of the first aspect, the present disclosure provides a compound (Compound 1A) of the general formula (I- A), or a compound (Compound IB) of the general formula (I-B):

Formula (I-B), each in free or salt form, wherein: n is an integer from 0-20 (e.g., 0-10); m is an integer from 1-100 (e.g., 25-75);

X is selected from a bond, CH ₂ , CH ₂ CH ₂ , CH ₂ C(0)-, -CH ₂ CH ₂ C(0)-, CH ₂ C(0)0-, - CH ₂ CH ₂ C(0)0-, -Geo)-, -C(0)-0-, -C(0)-N(R)-, -SCO)-, -S(0 ₂ )-, -S(0 ₂ )-0-, and -S(0 ₂ )-N(R)-;

Y is selected from CH ₂ , CH ₂ CH ₂ , -C(O)-, -C(0)-0-, -C(0)-N(R)-, -S(O)-, -S(0 ₂ )-, - S(0 ₂ )-0-, and -S(0 ₂ )-N(R)-;

R is selected from H and C1-C6 alkyl (e.g., methyl) optionally substituted by one or more

OH;

R ¹ is selected from a bond, Ci-C ₂ o alkyl, C ₂ -C ₂ o alkenyl, and C ₆ -C ₂ o aryl;

R ² is selected from H, OH, NH ₂ , NH(CI-CI ₂ alkyl), N(CI-CI ₂ alkyl)(Ci-Ci ₂ alkyl), - COOH, Ci-C ₆ alkyl, -0-Ci-Ci ₂ alkyl, -O-C ₆ -C ₂₀ aryl, -C(0)-Ci-Ci ₂ alkyl, -C(O)-C ₆ -C ₂₀ aryl, -O- C(0)-Ci-Ci ₂ alkyl, -O-C(O)-C ₆ -C ₂₀ aryl, -C(0)-0-Ci-Ci ₂ alkyl, -C(O)-O-C ₆ -C ₂₀ aryl, -O-C(O)- 0-Ci-Ci ₂ alkyl, -O-C(O)-O-C ₆ -C ₂₀ aryl, -C(0)-NH ₂ , -C(0)-NH(CI-CI ₂ alkyl), -C(0)-N(CI-CI ₂ alkyl) ₂ , -C(0)-NH-aryl, -0-C(0)-NH(CI-CI ₂ alkyl), -0-C(0)-N(CI-CI ₂ alkyl) ₂ , -0-C(0)-NH- aryl, -SO3H, -S0 ₂ NH ₂ , -S(0)-Ci-Ci ₂ alkyl, -S(O)-C ₆ -C ₂₀ aryl, -S(0) ₂ -Ci-Ci ₂ alkyl, -S(O) ₂ -C ₆ -C ₂₀ aryl, -0-S(0) ₂ -Ci-Ci ₂ alkyl, -0-S(0) ₂ -C ₆ -C ₂ o aryl, -S(0) ₂ -0-Ci-Ci ₂ alkyl, -S(O) ₂ -O-C ₆ -C ₂₀ aryl, -S(0) ₂ -NH(C _I -C _I2 alkyl), -S(0) ₂ -N(C _I -C _I2 alkyl) ₂ , -0-S(0) ₂ -0H, -0-P(0) ₂ (0H), and - P(0)(OH) ₂ ; wherein each of said Ci-Ci ₂ alkyl and C ₆ -C ₂ o aryl moieties, are independently optionally further substituted by one or more groups selected from halo (-F, -Cl, - Br, or -I), -CN, OH, NH ₂ , NH(C _I -C _I2 alkyl), N(C _I -C _I2 alkyl)(Ci-Ci ₂ alkyl), - COOH, -0-Ci-Ci ₂ alkyl, -C(0)-Ci-Ci ₂ alkyl, -0-C(0)-Ci-Ci ₂ alkyl, -C(0)-0-Ci- Ci ₂ alkyl, S0 ₃ H, -S0 ₂ NH ₂ , -0-S(0) ₂ -0H, -0-P(0) ₂ (0H), and -P(0)(0H) ₂ . [00014] In further embodiments of the first aspect, the present disclosure provides as follows:

1.1 The compound of Formula I-A.

1.2 The compound of Formula I-B .

1.3 Compound 1.2, wherein n is an integer from 0-10, e.g., 0-8, or 0-6, or 0-5, or any of 0, 1, 2, 3, or 4.

1.4 Compound 1.2, wherein n is 0, 1, 2 or 3.

1.5 Compound 1.2, wherein n is 0.

1.6 Compound 1.2, wherein n is 1.

1.7 Any one of compounds 1.1-1.6, wherein m is an integer from 1-75, e.g., 1-25, 25-

50, 50-75, 25-75, 1-10, 11-20, 21-30, 31-40, 41-50, 51-60, 61-75, or any combination thereof.

1.8 Any one of compounds 1.1-1.7, wherein X is selected from a bond, CH ₂ , -C(O)-, - C(0)-0-, and -C(0)-N(R)-.

1.9 Any one of compounds 1.1-1.7, wherein X is selected from -S(O)-, -S(0 ₂ )-, - S(0 ₂ )-0-, and -S(0 ₂ )-N(R)-.

1.10 Any one of compounds 1.1-1.7, wherein X is selected from a bond, CH ₂ , -C(O)-, and -C(0)-0-.

1.11 Any one of compounds 1.1-1.7, wherein X is abond.

1.12 Any one of compounds 1.1-1.11, wherein Y is selected from CH ₂ , CH ₂ CH ₂ , - C(O)-, -C(0)-0-, and -C(0)-N(R)-.

1.13 Any one of compounds 1.1-1.11, wherein Y is selected from -S(O)-, -S(0 ₂ )-, - S(0 ₂ )-0-, and -S(0 ₂ )-N(R)-. 1.14 Any one of compounds 1.1-1.11, wherein Y is selected from C¾, CH2CH2, and - C(O)-.

1.15 Any one of compounds 1.1-1.11, wherein Y is selected from CH2 and CH2CH2.

1.16 Any one of compounds 1.1-1.13, wherein R is H.

1.17 Any one of compounds 1.1-1.13, wherein R is C1-C6 alkyl (e.g., methyl, ethyl, propyl).

1.18 Any one of compounds 1.1-1.13, wherein R is C1-C6 alkyl substituted by one or more OH, e.g., R is selected from hydroxyethyl, hydroxypropyl, hydroxybutyl, hydroxypentyl, and hydroxyhexyl.

1.19 Compound 1.18, wherein R is selected from -CH2CH2OH, -CH(OH)CH3, - CH(OH)CH ₂ (OH), -CH2CH2CH2OH, -CH ₂ CH(OH)CH , -CH(OH)CH ₂ CH ₃ , - CH ₂ CH(OH)CH ₂ OH, -CH(OH)CH ₂ CH ₂ OH, -CH(OH)CH(OH)CH ₃ , and - CH(OH)CH(OH)CH ₂ OH.

1.20 Any one of compounds 1.1-1.19, wherein R ¹ is selected from a bond, C1-C20 alkyl, and C2-C20 alkenyl.

1.21 Compound 1.20, wherein R ¹ is a C _6-18 alkyl, e.g., C _6-12 alkyl, C _12-18 alkyl, C _6-10 alkyl, C 10-14 alkyl, or C14-18 alkyl.

1.22 Compound 1.20, wherein R ¹ is a C6-18 alkenyl, e.g., C6-12 alkenyl, C12-18 alkenyl, C6-10 alkenyl, C 10-14 alkenyl, or C14-18 alkenyl, each of which may optionally be monounsaturated or di-unsaturated.

1.23 Compound 1.20, wherein R ¹ is a Ci- ₃ alkyl, e.g., CH2 or CH2CH2.

1.24 Any one of compounds 1.1-1.23, wherein R ² is selected from H, OH, NH2, NH(Ci-Ci2 alkyl), N(Ci-Ci ₂ alkyl)(Ci-Ci ₂ alkyl), and -COOH.

1.25 Any one of compounds 1.1-1.23, wherein R ² is selected from C1-C6 alkyl, -O-Ci- C12 alkyl, -O-C ₆ -C ₂₀ aryl, -C(0)-Ci-Ci ₂ alkyl, -C(0)-C ₆ -C ₂ o aryl, -0-C(0)-Ci-Ci ₂ alkyl, - 0-C(0)-C ₆ -C ₂ o aryl, -C(0)-0-Ci-Ci ₂ alkyl, -C(0)-0-C ₆ -C ₂ o aryl, -0-C(0)-0-Ci-Ci ₂ alkyl, -0-C(0)-0-C ₆ -C ₂ o aryl, -C(0)-NH ₂ , -C(0)-NH(C _I -C _I2 alkyl), -C(0)-N(C _I -C _I2 alkyl) ₂ , -C(0)-NH-aryl, -0-C(0)-NH(CI-CI ₂ alkyl), -0-C(0)-N(CI-CI ₂ alkyl) ₂ , and -O- C(0)-NH-aryl.

1.26 Any one of compounds 1.1-1.23, wherein R ² is selected from -S0 ₃ H, -SO2NH2, - S(0)-Ci-Ci ₂ alkyl, -S(0)-C ₆ -C ₂ o aryl, -S(0) ₂ -Ci-Ci ₂ alkyl, -S(0) ₂ -C ₆ -C ₂ oaryl, -0-S(0) ₂ - C1-C12 alkyl, -0-S(0)2-C ₆ -C ₂ o aryl, -S(0) ₂ -0-Ci-Ci ₂ alkyl, -S(0) ₂ -0-C ₆ -C2oaiyl, -S(0) ₂ , NH(Ci-Ci2 alkyl), -S(0) ₂ -N(CI-CI ₂ alkyl) ₂ , -0-S(0) ₂ -0H, -0-P(0) ₂ (0H), and - P(0)(0H)2.

1.27 Any one of compounds 1.1-1.23, wherein R ² is selected from C1-C6 alkyl, -O-Ci- C12 alkyl, -C(0)-Ci-Ci2 alkyl, -0-C(0)-Ci-Ci ₂ alkyl, -C(0)-0-Ci-Ci ₂ alkyl, -0-C(0)-0- C1-C12 alkyl, -C(0)-NH ₂ , -C(0)-NH(CI-CI ₂ alkyl), -C(0)-N(CI-CI ₂ alkyl) ₂ , -O-C(O)- NH(Ci-Ci2 alkyl), -0-C(0)-N(CI-CI ₂ alkyl) ₂ ), -SO3H, -SO2NH2, -S(0)-Ci-Ci ₂ alkyl, - S(0) ₂ -Ci-Ci2 alkyl, -0-S(0) ₂ -Ci-Ci ₂ alkyl, -S(0) ₂ -0-Ci-Ci ₂ alkyl, -S(0) ₂ , NH(CI-CI ₂ alkyl), -S(0) ₂ -N(CI-CI ₂ alkyl) ₂ , -0-S(0) ₂ -0H, -0-P(0) ₂ (0H), and -P(0)(0H) ₂ .

1.28 Any one of compounds 1.1-1.23, wherein R ² is selected from H, OH, NH2, NHCH3, NH(CH ₃ )2, 0CH3, -C(0)CH ₃ , -0-C(0)-CH ₃ , -COOH, -SO3H, -0-S(0) ₂ -0H, - 0-P(0) ₂ (0H), and -P(0)(0H) ₂ .

1.29 Any one of compounds 1.1-1.28, wherein the alkyl and/or aryl moieties of R ² are each unsubstituted.

1.30 Any one of compounds 1.1-1.28, wherein the alkyl and/or aryl moieties of R ² are each independently further substituted by one or more groups selected from halo (-F, -Cl, -Br, or -I), -CN, OH, NH ₂ , NH(Ci-C 12 alkyl), N(Ci-Ci ₂ alkyl)(Ci-Ci ₂ alkyl), -COOH, -O- C1-C12 alkyl, -C(0)-Ci-Ci2 alkyl, -0-C(0)-Ci-Ci ₂ alkyl, -C(0)-0-Ci-Ci ₂ alkyl, -SO3H, - SO2NH2, -0-S(0) ₂ -0H, -0-P(0) ₂ (0H), and -P(0)(0H) ₂ .

1.31 Any one of compounds 1.1-1.28, wherein the alkyl and/or aryl moieties of R ² are each independently further substituted by one or more groups selected from halo (-F, -Cl, -Br, or -I), -CN, OH, NH ₂ , NH(Ci-C 12 alkyl), N(Ci-Ci ₂ alkyl)(Ci-Ci ₂ alkyl), -COOH, - SO3H, -SO2NH2, -0-S(0) ₂ -0H, -0-P(0) ₂ (0H), and -P(0)(0H) ₂ .

1.32 Any one of compounds 1.1-1.28, wherein the alkyl and/or aryl moieties of R ² are each independently further substituted by one or more groups selected from halo (-F, -Cl, -Br, or -I), - OH, NH ₂ , -COOH, -SO3H, -SO2NH2, -0-S(0) ₂ -0H, -0-P(0) ₂ (0H), and - P(0)(0H)2.

1.33 Any one of compounds 1.1-1.28, wherein the alkyl and/or aryl moieties of R ² are each independently further substituted by one or more groups selected from halo (-F, -Cl, -Br, or -I), - OH, NH ₂ , -COOH, and -SO3H. 1.34 Any one of compounds 1.1-1.28, wherein the alkyl and/or aryl moieties of R ² are each independently further substituted by one or more OH.

1.35 Any one of compounds 1.1-1.23, wherein R ² is selected from C1-C6 alkyl, -O-Ci- C ₆ alkyl, -C(0)-Ci-C ₆ alkyl, -0-C(0)-Ci-C ₆ alkyl, -C(0)-0-Ci-C ₆ alkyl, -0-C(0)-0-Ci- Ce alkyl, wherein each of said alkyl is optionally substituted by one or more OH.

1.36 Any one of compounds 1.1-1.23, wherein R ² is selected from -O-C1-C3 alkyl, - C(0)-Ci-C ₃ alkyl, -0-C(0)-Ci-C ₃ alkyl, -C(0)-0-Ci-C ₃ alkyl, -0-C(0)-0-Ci-C ₃ alkyl, wherein each of said alkyl is optionally substituted by one or more OH.

1.37 Compound 1.36, wherein each of said C1-C3 alkyl is selected from -CH2CH2OH, - CH(OH)CH ₃ , -CH(OH)CH ₂ (OH), -CH2CH2CH2OH, -CH ₂ CH(OH)CH ₃ , - CH(OH)CH ₂ CH ₃ , -CH ₂ CH(OH)CH ₂ OH, -CH(OH)CH ₂ CH ₂ OH, -CH(OH)CH(OH)CH ₃ , and -CH(OH)CH(OH)CH ₂ OH.

1.38 Compound 1.37, wherein each of said Ci-C ₃ alkyl is selected from -CH2CH2OH, - CH(OH)CH ₂ (OH), -CH ₂ CH(OH)CH ₃ , -CH ₂ CH(OH)CH ₂ OH, and - CH(OH)CH(OH)CH ₂ OH.

1.39 Compound 1.37, wherein R ² is selected from -OCH2CH2OH, -OCH2CH(OH)CH ₃ , -OCH ₂ CH(OH)CH ₂ OH, -(CO)-CH ₂ CH ₂ OH, -(CO)-CH ₂ CH(OH)CH ₃ , -C(0)- CH ₂ CH(OH)CH ₂ OH, -0(C0)-CH ₂ CH ₂ 0H, -0(C0)-CH ₂ CH(0H)CH ₃ , -0C(0)- CH ₂ CH(OH)CH ₂ OH, -(C0)-0-CH ₂ CH ₂ 0H, -(C0)-0-CH ₂ CH(0H)CH ₃ , and -C(0)-0- CH ₂ CH(OH)CH ₂ OH.

1.40 Any preceding compound, wherein:

X is a bond, and Y is H; or

X is a bond, Y is -C(O)-, R ¹ is CH ₂ or CH2CH2, and R ² is -COOH; or X is a bond, Y is -C(O)-, R ¹ is CH ₂ or CH2CH2, and R ² is -S0 ₃ H or -0-S(0) ₂ 0H; or

X is a bond, Y is -S(0) ₂ -, R ¹ is a bond, and R ² is OH; or X is a bond, Y is -C(O)-, R ¹ is a bond, and R ² is CH2CH2OH; or X is a bond, Y is -C(O)-, R ¹ is a bond, and R ² is CH ₂ CH(OH)CH ₂ OH; or X is a bond, Y is -C(O)-, R ¹ is a bond, and R ² is CH ₃ .

1.41 Any preceding compound which comprises any group -COOH, -S0 ₃ H, -0-S(0) ₂ - OH, -0-P(0) ₂ (0H), or -P(0)(0H) ₂ , wherein said group is in the form of a salt, e.g., an alkali metal salt (e.g., lithium, sodium or potassium salt), or an alkaline earth metal salt (e.g., magnesium or calcium salt).

1.42 Any preceding compound which comprises any basic amine group (e.g., -Nth), wherein said group is in the form of an acid addition salt, e.g., a salt with strong Bronsted acid (e.g., hydrochloride, sulfate, phosphate salt).

1.43 Any preceding compound wherein the terminal groups of the compound of Formula I-A or I-B are each:

1.44 Any preceding compound wherein the terminal groups of the compound of Formula I-A or I-B are each:

[00015] In a second embodiment of the first aspect, the present disclosure provides a compound (Compound 2A) of the general formula (II-A), or a compound (Compound 2B) of the general formula (II-B):

Formula (II-B), each in free or salt form, wherein: n is an integer from 0-20 (e.g., 0-10); m is an integer from 1-100 (e.g., 25-75);

X is selected from a bond, CH ₂ , CH ₂ CH ₂ , CH ₂ C(0)-, -CH ₂ CH ₂ C(0)-, CH ₂ C(0)0-, -

CH ₂ CH ₂ C(0)0-, -C(0)-, -C(0)-0-, -C(0)-N(R)-, -S(0)-, -S(0 ₂ )-, -S(0 ₂ )-0-, and -S(0 ₂ )-N(R)-; Y is selected from CH ₂ CH ₂ , -C(O)-, -CH ₂ CH ₂ -C(0)-, -CH ₂ CH ₂ -C(0)-0-, -S(O)-, or -

S(0 ₂ )-;

R is selected from H and C1-C6 alkyl (e.g., methyl) optionally substituted by one or more

OH; each R ³ is independently selected from H, Ci-C ₂ o alkyl, C ₂ -C ₂ o alkenyl, -C(0)-Ci-C ₂ o alkyl, -C(O)-C ₂ -C ₂₀ alkenyl, -(CH ₂ CH ₂ 0) _m -CH ₂ CH ₂ 0H, -(CH ₂ CH ₂ O) _m -CH ₂ CH ₂ O-Ci-C ₂₀ alkyl, -(CH ₂ CH ₂ O)m-CH ₂ CH ₂ O-C ₂ -C ₂₀ alkenyl, -(CH ₂ CH ₂ O) _m -CH ₂ CH ₂ O-C(O)-Ci-C ₂₀ alkyl, - (CH ₂ CH ₂ O) _m -CH ₂ CH ₂ O-C(O)-C ₂ -C ₂₀ alkenyl, -(CH ₂ CH(CH ₃ )0) _m -CH ₂ CH(CH ₃ )0H, -(CH ₂ C H(CH ₃ )O)m-CH ₂ CH(CH ₃ )O-Ci-C ₂₀ alkyl, -(CH ₂ CH(CH ₃ )O) _m -CH ₂ CH(CH ₃ )O-C ₂ -C ₂₀ alkenyl, - (CH ₂ CH(CH ₃ )O)m-CH ₂ CH(CH ₃ )O-C(O)-Ci-C ₂₀ alkyl, and -(CH ₂ CH(CH ₃ )0) _m -CH ₂ CH(CH ₃ )0- C(O)-C ₂ -C ₂₀ alkenyl, -CH ₂ CH ₂ OH, -CH ₂ CH(CH ₃ )OH, -CH ₂ COOH, -CH ₂ CH ₂ COOH, -S(0) ₂ - OH, and -P(0) ₂ (OH), or one or both R ³ is a structure having the formula: wherein X, Y, n and m are each independently as defined herein above.

[00016] In further embodiments of the first aspect, the present disclosure provides as follows:

2.1 The compound of Formula II- A.

2.2 The compound of Formula II-B .

2.3 Compound 2.2, wherein n is an integer from 0-10, e.g., 0-8, or 0-6, or 0-5, or any of 0, 1, 2, 3, or 4.

2.4 Compound 2.2, wherein n is 0, 1, 2 or 3.

2.5 Compound 2.2, wherein n is 0.

2.6 Compound 2.2, wherein n is 1.

2.7 Any one of compounds 2.1-2.6, wherein m is an integer from 1-75, e.g., 1-25, 25- 50, 50-75, 25-75, 1-10, 11-20, 21-30, 31-40, 41-50, 51-60, 61-75, or any combination thereof.

2.8 Any one of compounds 2.1-2.7, wherein X is selected from CH ₂ , -C(O)-, -C(O)- 0-, and -C(0)-N(R)-. 2.9 Any one of compounds 2.1-2.7, wherein X is selected from -S(O)-, -S(0 ₂ )-, - S(0 ₂ )-0-, and -S(0 ₂ )-N(R)-.

2.10 Any one of compounds 2.1-2.7, wherein X is selected from a bond, CH ₂ , -C(O)-, and -C(0)-0-.

2.11 Any one of compounds 2.1-2.7, wherein X is a bond.

2.12 Any one of compounds 2.1-2.11, wherein Y is selected from CH ₂ CH ₂ , -C(O)-, - CH ₂ CH ₂ -C(0)-, and -CH ₂ CH ₂ -C(0)-0-.

2.13 Any one of compounds 2.1-2.11, wherein Y is selected from -S(O)-, and -S(0 ₂ )-.

2.14 Any one of compounds 2.1-2.11, wherein Y is CH ₂ CH ₂ .

2.15 Any one of compounds 2.1-2.11, wherein Y is -C(O)-.

2.16 Any one of compounds 2.1-2.15, wherein R is H.

2.17 Any one of compounds 2.1-2.15, wherein R is C1-C6 alkyl (e.g., methyl, ethyl, propyl).

2.18 Any one of compounds 2.1-2.15, wherein R is C1-C6 alkyl substituted by one or more OH, e.g., R is selected from hydroxyethyl, hydroxypropyl, hydroxybutyl, hydroxypentyl, and hydroxhexyl.

2.19 Compound 2.18, wherein R is selected from -CH ₂ CH ₂ OH, -CH(OH)CH3, - CH(OH)CH ₂ (OH), -CH ₂ CH ₂ CH ₂ OH, -CH ₂ CH(OH)CH ₃ , -CH(OH)CH ₂ CH ₃ , - CH ₂ CH(OH)CH ₂ OH, -CH(OH)CH ₂ CH ₂ OH, -CH(OH)CH(OH)CH ₃ , and - CH(OH)CH(OH)CH ₂ OH.

2.20 Any one of compounds 2.1-2.19, wherein R ³ is selected from H, Ci-C ₂ o alkyl, and C ₂ -C ₂ o alkenyl.

2.21 Compound 2.20, wherein R ³ is a C _6-i s alkyl, e.g., C _6-i2 alkyl, Ci _2-i s alkyl, C6-10 alkyl, Cio-14 alkyl, or Ci4-is alkyl.

2.22 Compound 2.20, wherein R ³ is a C6-18 alkenyl, e.g., C _6-i2 alkenyl, Ci _2-i s alkenyl, C6-10 alkenyl, C 10-14 alkenyl, or C14-18 alkenyl, each of which may optionally be monounsaturated or di-unsaturated.

2.23 Compound 2.20, wherein R ³ is a Ci- ₃ alkyl, e.g., CH ₂ or CH ₂ CH ₂ .

2.24 Any one of compounds 2.1-2.19, wherein R ³ is -C(0)-Ci-C ₂ o alkyl or -C(0)-C ₂ - C ₂ o alkenyl. 2.25 Compound 2.24, wherein R ³ is a -C(0)-C _6-i s alkyl, e.g., -C(0)-C _6-i2 alkyl, -C(O)- C12-18 alkyl, -C(0)-C _6-i o alkyl, -C(0)-Cio-i4 alkyl, or -C(0)-Ci _4-i8 alkyl.

2.26 Compound 2.24, wherein R ³ is a -C(0)-C ₆ -is alkenyl, e.g., -C(0)-C ₆ -i ₂ alkenyl, - C(0)-Ci2-18 alkenyl, -C(0)-C6-io alkenyl, -C(0)-Cio-i4 alkenyl, or -C(0)-Ci4-is alkenyl, each of which may optionally be monounsaturated or di-unsaturated.

2.27 Any one of compounds 2.1-2.19, wherein R ³ is -(CthCthOV-CthCthOH, wherein m is an integer from 1-75, e.g., 1-25, 25-50, 50-75, 25-75, 1-10, 11-20, 21-30, 31-40, 41-50, 51-60, 61-75, or any combination thereof.

2.28 Any one of compounds 2.1-2.19, wherein R ³ is selected from -(CthCthOV- CH2CH2O-C1-C20 alkyl, -(CH ₂ CH2O) _m -CH2CH ₂ O-C2-C20 alkenyl, -(CH ₂ CH ₂ 0) _m - CH ₂ CH ₂ 0-C(0)-CI-C _2O alkyl, and -(CH2CH ₂ O) _m -CH2CH ₂ O-C(O)-C2-C20 alkenyl.

2.29 Compound 2.28, wherein m is an integer from 1-75, e.g., 1-25, 25-50, 50-75, 25- 75, 1-10, 11-20, 21-30, 31-40, 41-50, 51-60, 61-75, or any combination thereof.

2.30 Compound 2.28 or 2.29, wherein said C ₁ -C ₂₀ alkyl is a C _6-18 alkyl, e.g., C _6-12 alkyl, C12-18 alkyl, C6-10 alkyl, C 10-14 alkyl, or C14-18 alkyl.

2.31 Compound 2.28 or 2.29, wherein said C2-C20 alkenyl is a C6-18 alkenyl, e.g., C6-12 alkenyl, C12-18 alkenyl, C6-10 alkenyl, Cio-14 alkenyl, or C14-18 alkenyl.

2.32 Any one of compounds 2.1-2.19, wherein R ³ is: , wherein X, Y and m are as defined in any of 2.1-

2.19.

2.33 Any one of compounds 2.1-2.19, wherein R ³ is: , wherein

X, Y, n and m are as defined in any of 2.1-2.19.

2.34 Any one of compounds 2.1-2.19, wherein R ³ is -CH2CH2OH, -CH2CH(CH3)OH, - CH2COOH, -CH2CH2COOH, -S(0) ₂ -0H, or -P(0) ₂ (0H).

2.35 Any preceding compound, wherein:

X is a bond, and Y is CH2CH2; or X is a bond, and Y is -C(O)-; or

X is a bond, and Y is - CfhCfh-CXO)-; or X is a bond, and Y is -S(0) ₂ -.

2.36 Compound 2.35, wherein R ³ is H.

2.37 Compound 2.35, wherein R ³ is -CH ₂ CH ₂ OH, -CH ₂ CH(CH ₃ )OH, - CHiCOOH, - CH2CH2COOH, ^(Co _l -Oil, or -P(0) ₂ (0H).

2.38 Compound 2.35, wherein the compound is the compound of Formula II-A and wherein R ³ is: , wherein X, Y and m are as defined for the compound of Formula II-A (i.e., all values of X, Y and m are the same in the compound).

2.39 Compound 2.34, wherein the compound is the compound of Formula II-B and wherein R ³ is: , wherein

X, Y, n, and m are as defined for the compound of Formula II-A (i.e., all values of X, Y, n, and m are the same in the compound).

2.40 Any preceding compound which comprises any group -COOH, -S(0) ₂ -0H, or - P(0) ₂ (0H), wherein said group is in the form of a salt, e.g., an alkali metal salt (e.g., lithium, sodium or potassium salt), or an alkaline earth metal salt (e.g., magnesium or calcium salt).

2.41 Any preceding compound which comprises any basic amine group (e.g., -NFh), wherein said group is in the form of an acid addition salt, e.g., a salt with strong Bronsted acid (e.g., hydrochloride, sulfate, phosphate salt).

2.42 Any preceding compound wherein the terminal groups of the compound of Formula II-A or II-B are each:

2.43 Any preceding compound wherein the terminal groups "g "g- of the compound of Formula II-A or II-B are each: [00017] In a third embodiment of the first aspect, the present disclosure provides a compound (Compound 3 A) of the general formula (III- A), or a compound (Compound 3B) of the general formula (III-B):

Formula (III-B), each in free or salt form, wherein: n is an integer from 0-20 (e.g., 0-10); m is an integer from 1-100 (e.g., 25-75);

X is selected from a bond, CH ₂ , CH ₂ CH ₂ , CH ₂ C(0)-, -CH ₂ CH ₂ C(0)-, CH ₂ C(0)0-, - CH ₂ CH ₂ C(0)0-, -C(0)-, -C(0)-0-, -C(0)-N(R)-, -Sic ⁾ )-, -S(0 ₂ )-, -S(0 ₂ )-0-, and -S(0 ₂ )-N(R)-;

Y is selected from CH ₂ , CH ₂ CH ₂ , -C(O)-, -C(0)-0-, -C(0)-N(R)-, -S(O)-, -S(0 ₂ )-, - S(0 ₂ )-0-, and -S(0 ₂ )-N(R)-;

R is selected from H and C1-C6 alkyl (e.g., methyl) optionally substituted by one or more

OH;

R ¹ is selected from a bond, Ci-C ₂ o alkyl, C ₂ -C ₂ o alkenyl, and C ₆ -C ₂ o aryl;

R ² is selected from H, OH, NH ₂ , NH(C _I -C _I2 alkyl), N(C _I -C _I2 alkyl)(Ci-Ci ₂ alkyl), - COOH, Ci-C ₆ alkyl, -0-Ci-Ci ₂ alkyl, -O-C ₆ -C ₂₀ aryl, -C(0)-Ci-Ci ₂ alkyl, -C(O)-C ₆ -C ₂₀ aryl, -O- C(0)-Ci-Ci ₂ alkyl, -O-C(O)-C ₆ -C ₂₀ aryl, -C(0)-0-Ci-Ci ₂ alkyl, -C(O)-O-C ₆ -C ₂₀ aryl, -O-C(O)- 0-Ci-Ci ₂ alkyl, -O-C(O)-O-C ₆ -C ₂₀ aryl, -C(0)-NH ₂ , -C(0)-NH(C _I -C _I2 alkyl), -C(0)-N(C _I -C _I2 alkyl) ₂ , -C(0)-NH-aryl, -0-C(0)-NH(C _I -C _I2 alkyl), -0-C(0)-N(C _I -C _I2 alkyl) ₂ , -0-C(0)-NH- aryl, -SO3H, -S0 ₂ NH ₂ , -S(0)-Ci-Ci ₂ alkyl, -S(O)-C ₆ -C ₂₀ aryl, -S(0) ₂ -Ci-Ci ₂ alkyl, -S(O) ₂ -C ₆ -C ₂₀ aryl,-0-S(0) ₂ -Ci-Ci ₂ alkyl, -O-S(O) ₂ -C ₆ -C ₂₀ aryl, -S(0) ₂ -0-Ci-Ci ₂ alkyl, -S(O) ₂ -O-C ₆ -C ₂₀ aryl, - S(0) ₂ -NH(C _I -C _I2 alkyl), -S(0) ₂ -N(C _I -C _I2 alkyl) ₂ , -0-S(0) ₂ -0H, -0-P(0) ₂ (0H), and - P(0)(OH) ₂ ; wherein each of said Ci-Ci ₂ alkyl and C6-C ₂ o aryl moieties, are independently optionally further substituted by one or more groups selected from halo (-F, -Cl, - Br, or -I), -CN, OH, NH ₂ , NH(C _I -C _I2 alkyl), N(C _I -C _I2 alkyl)(Ci-Ci ₂ alkyl), - COOH, -O-C1-C12 alkyl, -C(0)-Ci-Ci ₂ alkyl, -0-C(0)-Ci-Ci ₂ alkyl, -C(0)-0-Ci- C12 alkyl, SO3H, -SO2NH2, -0-S(0) ₂ -0H, -0-P(0) ₂ (0H), and -P(0)(0H) ₂ . [00018] In further embodiments of the first aspect, the present disclosure provides as follows:

3.1 The compound of Formula III- A.

3.2 The compound of Formula III-B .

3.3 Compound 3.2, wherein n is an integer from 0-10, e.g., 0-8, or 0-6, or 0-5, or any of 0, 1, 2, 3, or 4.

3.4 Compound 3.2, wherein n is 0, 1, 2 or 3.

3.5 Compound 3.2, wherein n is 0.

3.6 Compound 3.2, wherein n is 1.

3.7 Any one of compounds 3.1-3.6, wherein m is an integer from 1-75, e.g., 1-25, 25-

50, 50-75, 25-75, 1-10, 11-20, 21-30, 31-40, 41-50, 51-60, 61-75, or any combination thereof.

3.8 Any one of compounds 3.1-3.7, wherein X is selected from a bond, CFh, -C(O)-, - C(0)-0-, and -C(0)-N(R)-.

3.9 Any one of compounds 3.1-3.7, wherein X is selected from -S(O)-, -S(02)-, - S(0 ₂ )-0-, and -S(0 ₂ )-N(R)-.

3.10 Any one of compounds 3.1-3.7, wherein X is selected from a bond, CFh, -C(O)-, and -C(0)-0-.

3.11 Any one of compounds 3.1-3.7, wherein X is abond.

3.12 Any one of compounds 3.1-3.11, wherein Y is selected from CFh, CFhCFh, - C(O)-, -C(0)-0-, and -C(0)-N(R)-.

3.13 Any one of compounds 3.1-3.11, wherein Y is selected from -S(O)-, -S(Ch)-, - S(0 ₂ )-0-, and -S(0 ₂ )-N(R)-.

3.14 Any one of compounds 3.1-3.11, wherein Y is selected from CFh, CFhCFh, and - C(O)-.

3.15 Any one of compounds 3.1-3.11, wherein Y is selected from CFh and CFhCFh.

3.16 Any one of compounds 3.1-3.13, wherein R is H.

3.17 Any one of compounds 3.1-3.13, wherein R is C1-C6 alkyl (e.g., methyl, ethyl, propyl). 3.18 Any one of compounds 3.1-3.13, wherein R is C1-C6 alkyl substituted by one or more OH, e.g., R is selected from hydroxyethyl, hydroxypropyl, hydroxybutyl, hydroxypentyl, and hydroxhexyl.

3.19 Compound 3.18, wherein R is selected from -CH2CH2OH, -CH(OH)CH3, - CH(OH)CH ₂ (OH), -CH2CH2CH2OH, -CH ₂ CH(OH)CH , -CH(OH)CH ₂ CH ₃ , - CH ₂ CH(OH)CH ₂ OH, -CH(OH)CH ₂ CH ₂ OH, -CH(OH)CH(OH)CH ₃ , and - CH(OH)CH(OH)CH ₂ OH.

3.20 Any one of compounds 3.1-3.19, wherein R ¹ is selected from a bond, C1-C20 alkyl, and C2-C20 alkenyl.

3.21 Compound 3.20, wherein R ¹ is a C6-18 alkyl, e.g., C6-12 alkyl, C12-18 alkyl, C6-10 alkyl, C 10-14 alkyl, or C14-18 alkyl.

3.22 Compound 3.20, wherein R ¹ is a C6-18 alkenyl, e.g., C6-12 alkenyl, C12-18 alkenyl, C6-10 alkenyl, C 10-14 alkenyl, or C14-18 alkenyl, each of which may optionally be monounsaturated or di-unsaturated.

3.23 Compound 3.20, wherein R ¹ is a Ci- ₃ alkyl, e.g., CH2 or CH2CH2.

3.24 Any one of compounds 3.1-3.23, wherein R ² is selected from H, OH, NH2, NH(Ci-Ci2 alkyl), N(Ci-Ci ₂ alkyl)(Ci-Ci ₂ alkyl), and -COOH.

3.25 Any one of compounds 3.1-3.23, wherein R ² is selected from C1-C6 alkyl, -O-Ci- C12 alkyl, -O-C ₆ -C ₂₀ aryl, -C(0)-Ci-Ci ₂ alkyl, -C(0)-C ₆ -C ₂ o aryl, -0-C(0)-Ci-Ci ₂ alkyl, - 0-C(0)-C ₆ -C ₂ o aryl, -C(0)-0-Ci-Ci ₂ alkyl, -C(0)-0-C ₆ -C ₂ o aryl, -0-C(0)-0-Ci-Ci ₂ alkyl, -0-C(0)-0-C ₆ -C ₂ o aryl, -C(0)-NH ₂ , -C(0)-NH(C _I -C _I2 alkyl), -C(0)-N(C _I -C _I2 alkyl) ₂ , -C(0)-NH-aryl, -0-C(0)-NH(CI-CI ₂ alkyl), -0-C(0)-N(CI-CI ₂ alkyl) ₂ , and -O- C(0)-NH-aryl.

3.26 Any one of compounds 3.1-3.23, wherein R ² is selected from -S0 ₃ H, -SO2NH2, - S(0)-Ci-Ci ₂ alkyl, -S(0)-C ₆ -C ₂ o aryl, -S(0) ₂ -Ci-Ci ₂ alkyl, -S(0) ₂ -C ₆ -C ₂ oaryl, -0-S(0) ₂ - C1-C12 alkyl, -0-S(0) ₂ -C ₆ -C ₂ o aryl, -S(0) ₂ -0-Ci-Ci ₂ alkyl, -S(0)2-0-C ₆ -C ₂ oaryl, -S(0) ₂ , NH(Ci-Ci2 alkyl), -S(0) ₂ -N(C _I -C _I2 alkyl) ₂ , -0-S(0) ₂ -0H, -0-P(0) ₂ (0H), and - P(0)(0H)2.

3.27 Any one of compounds 3.1-3.23, wherein R ² is selected from C1-C6 alkyl, -O-Ci- C12 alkyl, -C(0)-Ci-Ci2 alkyl, -0-C(0)-Ci-Ci ₂ alkyl, -C(0)-0-Ci-Ci ₂ alkyl, -0-C(0)-0- C1-C12 alkyl, -C(0)-NH ₂ , -C(0)-NH(CI-CI ₂ alkyl), -C(0)-N(CI-CI ₂ alkyl) ₂ , -O-C(O)- NH(Ci-Ci2 alkyl), -0-C(0)-N(CI-CI ₂ alkyl) ₂ ), -SO3H, -S0 ₂ NH ₂ , -S(0)-Ci-Ci ₂ alkyl, - S(0) ₂ -Ci-Ci2 alkyl, -0-S(0) ₂ -Ci-Ci ₂ alkyl, -S(0) ₂ -0-Ci-Ci ₂ alkyl, -S(0) ₂ , NH(CI-CI ₂ alkyl), -S(0) ₂ -N(C _I -C _I2 alkyl) ₂ , -0-S(0) ₂ -0H, -0-P(0) ₂ (0H), and -P(0)(0H) ₂ .

3.28 Any one of compounds 3.1-3.23, wherein R ² is selected from H, OH, NH ₂ , NHCH3, NH(CH ₃ ) ₂ , 0CH3, -C(0)CH ₃ , -0-C(0)-CH ₃ , -COOH, -SO3H, -0-S(0) ₂ -0H, - 0-P(0) ₂ (0H), and -P(0)(0H) ₂ .

3.29 Any one of compounds 3.1-3.28, wherein the alkyl and/or aryl moieties of R ² are each unsubstituted.

3.30 Any one of compounds 3.1-3.28, wherein the alkyl and/or aryl moieties of R ² are each independently further substituted by one or more groups selected from halo (-F, -Cl, -Br, or -I), -CN, OH, NH ₂ , NH(Ci-C 12 alkyl), N(Ci-Ci ₂ alkyl)(Ci-Ci ₂ alkyl), -COOH, -O- Ci-Ci2 alkyl, -C(0)-Ci-Ci ₂ alkyl, -0-C(0)-Ci-Ci ₂ alkyl, -C(0)-0-Ci-Ci ₂ alkyl, -SO3H, - S0 ₂ NH ₂ , -0-S(0) ₂ -0H, -0-P(0) ₂ (0H), and -P(0)(0H) ₂ .

3.31 Any one of compounds 3.1-3.28, wherein the alkyl and/or aryl moieties of R ² are each independently further substituted by one or more groups selected from halo (-F, -Cl, -Br, or -I), -CN, OH, NH ₂ , NH(Ci-C 12 alkyl), N(Ci-Ci ₂ alkyl)(Ci-Ci ₂ alkyl), -COOH, - SO3H, -SO2NH2, -0-S(0) ₂ -0H, -0-P(0) ₂ (0H), and -P(0)(0H) ₂ .

3.32 Any one of compounds 3.1-3.28, wherein the alkyl and/or aryl moieties of R ² are each independently further substituted by one or more groups selected from halo (-F, -Cl, -Br, or -I), - OH, NH ₂ , -COOH, -SO3H, -SO2NH2, -0-S(0) ₂ -0H, -0-P(0) ₂ (0H), and - P(0)(0H) ₂ .

3.33 Any one of compounds 3.1-3.28, wherein the alkyl and/or aryl moieties of R ² are each independently further substituted by one or more groups selected from halo (-F, -Cl, -Br, or -I), - OH, NH ₂ , -COOH, and SO3H.

3.34 Any one of compounds 3.1-3.28, wherein the alkyl and/or aryl moieties of R ² are each independently further substituted by one or more OH.

3.35 Any one of compounds 3.1-3.23, wherein R ² is selected from C1-C6 alkyl, -O-Ci- C ₆ alkyl, -C(0)-Ci-C ₆ alkyl, -0-C(0)-Ci-C ₆ alkyl, -C(0)-0-Ci-C ₆ alkyl, -0-C(0)-0-Ci- Ce alkyl, wherein each of said alkyl is optionally substituted by one or more OH. 3.36 Any one of compounds 3.1-3.23, wherein R ² is selected from -O-C1-C3 alkyl, - C(0)-Ci-C ₃ alkyl, -0-C(0)-Ci-C ₃ alkyl, -C(0)-0-Ci-C ₃ alkyl, -0-C(0)-0-Ci-C ₃ alkyl, wherein each of said alkyl is optionally substituted by one or more OH.

3.37 Compound 3.36, wherein each of said C1-C3 alkyl is selected from -CH2CH2OH, - CH(OH)CH ₃ , -CH(OH)CH ₂ (OH), -CH2CH2CH2OH, -CH ₂ CH(OH)CH ₃ , - CH(OH)CH ₂ CH ₃ , -CH ₂ CH(OH)CH ₂ OH, -CH(OH)CH ₂ CH ₂ OH, -CH(OH)CH(OH)CH ₃ , and -CH(OH)CH(OH)CH ₂ OH.

3.38 Compound 3.37, wherein each of said Ci-C ₃ alkyl is selected from CH2CH2OH, CH(OH)CH ₂ (OH), CH ₂ CH(OH)CH ₃ , CH ₂ CH(OH)CH ₂ OH, and CH(OH)CH(OH)CH ₂ OH.

3.39 Compound 3.37, wherein each of said Ci-C ₃ alkyl is selected from - OCH2CH2OH, -OCH ₂ CH(OH)CH ₃ , -OCH ₂ CH(OH)CH ₂ OH, -(CO)-CH ₂ CH ₂ OH, -(CO)- CH ₂ CH(OH)CH ₃ , -C(0)-CH ₂ CH(0H)CH ₂ 0H, -0(C0)-CH ₂ CH ₂ 0H, -O(CO)- CH ₂ CH(OH)CH ₃ , -0C(0)-CH ₂ CH(0H)CH ₂ 0H, -(C0)-0-CH ₂ CH ₂ 0H, -(CO)-O- CH ₂ CH(OH)CH ₃ , and -C(0)-0-CH ₂ CH(0H)CH ₂ 0H.

3.40 Any preceding compound, wherein:

X is a bond, and Y is H; or

X is a bond, Y is -C(O)-, R ¹ is CH ₂ or CH2CH2, and R ² is -COOH; or X is a bond, Y is -C(O)-, R ¹ is CH ₂ or CH2CH2, and R ² is -S0 ₃ H or -0-S(0) ₂ 0H; or

X is a bond, Y is -S(0) ₂ -, R ¹ is a bond, and R ² is OH; or X is a bond, Y is -C(O)-, R ¹ is a bond, and R ² is CH2CH2OH; or X is a bond, Y is -C(O)-, R ¹ is a bond, and R ² is CH ₂ CH(OH)CH ₂ OH; or X is a bond, Y is -C(O)-, R ¹ is a bond, and R ² is CH ₃ .

3.41 Any preceding compound which comprises any group -COOH, -S0 ₃ H, -0-S(0) ₂ - OH, -0-P(0) ₂ (0H), or -P(0)(0H) ₂ , wherein said group is in the form of a salt, e.g., an alkali metal salt (e.g., lithium, sodium or potassium salt), or an alkaline earth metal salt (e.g., magnesium or calcium salt).

3.42 Any preceding compound which comprises any basic amine group (e.g., -NH2), wherein said group is in the form of an acid addition salt, e.g., a salt with strong Bronsted acid (e.g., hydrochloride, sulfate, phosphate salt). 3.43 Any preceding compound wherein the terminal groups of the compound of Formula III-A or III-B are each:

3.44 Any preceding compound wherein the terminal groups of the compound of Formula III-A or III-B are each:

[00019] In a fourth embodiment of the first aspect, the present disclosure provides a compound (Compound 4 A) of the general formula (IV- A), or a compound (Compound 4B) of the general formula (IV-B):

Formula (IV-B), each in free or salt form, wherein: n is an integer from 0-20 (e.g., 0-10); m is an integer from 1-100 (e.g., 25-75);

X is selected from a bond, CH ₂ , CH ₂ CH ₂ , CH ₂ C(0)-, -CH ₂ CH ₂ C(0)-, CH ₂ C(0)0-, - CH ₂ CH ₂ C(0)0-, -C(0)-, -C(0)-0-, -C(0)-N(R)-, -Sic ⁾ )-, -S(0 ₂ )-, -S(0 ₂ )-0-, and -S(0 ₂ )-N(R)-; Y is selected from CH ₂ CH ₂ , -C(O)-, -CH ₂ CH ₂ -C(0)-, -CH ₂ CH ₂ -C(0)-0-, -S(O)-, or -

S(0 ₂ )-;

R is selected from H and C1-C6 alkyl (e.g., methyl) optionally substituted by one or more

OH; each R ³ is independently selected from H, Ci-C ₂ o alkyl, C ₂ -C ₂ o alkenyl, -C(0)-Ci-C ₂ o alkyl, -C(O)-C ₂ -C ₂₀ alkenyl, -(CH ₂ CH ₂ 0) _m -CH ₂ CH ₂ 0H, -(CH ₂ CH ₂ O) _m -CH ₂ CH ₂ O-Ci-C ₂₀ alkyl, -(CH ₂ CH ₂ O)m-CH ₂ CH ₂ O-C ₂ -C ₂₀ alkenyl, -(CH ₂ CH ₂ O) _m -CH ₂ CH ₂ O-C(O)-Ci-C ₂₀ alkyl, - (CH ₂ CH ₂ O) _m -CH ₂ CH ₂ O-C(O)-C ₂ -C ₂₀ alkenyl, -(CH ₂ CH(CH ₃ )0) _m -CH ₂ CH(CH )0H, -(CH ₂ C H(CH3)0) _m -CH ₂ CH(CH ₃ )0-Ci-C ₂ o alkyl, -(CH ₂ CH(CH3)0) _m -CH ₂ CH(CH ₃ )0-C ₂ -C ₂ o alkenyl, - (CH ₂ CH(CH3)0) _m -CH ₂ CH(CH ₃ )0-C(0)-Ci-C ₂ o alkyl, and -(CH ₂ CH(CH ₃ )0) _m -CH ₂ CH(CH ₃ )0- C(O)-C ₂ -C ₂₀ alkenyl, -CH ₂ CH ₂ OH, -CH ₂ CH(CH ₃ )OH, -CH ₂ COOH, -CH ₂ CH ₂ COOH, -S(0) ₂ - OH, and -P(0) ₂ (OH),or one or both R ³ is a structure having the formula: wherein X, Y, n and m are each independently as defined herein above.

[00020] In further embodiments of the first aspect, the present disclosure provides as follows:

4.1 The compound of Formula IV-A.

4.2 The compound of Formula IV-B.

4.3 Compound 4.2, wherein n is an integer from 0-10, e.g., 0-8, or 0-6, or 0-5, or any of 0, 1, 2, 3, or 4.

4.4 Compound 4.2, wherein n is 0, 1, 2 or 3.

4.5 Compound 4.2, wherein n is 0.

4.6 Compound 4.2, wherein n is 1.

4.7 Any one of compounds 4.1-4.6, wherein m is an integer from 1-75, e.g., 1-25, 25-

50, 50-75, 25-75, 1-10, 11-20, 21-30, 31-40, 41-50, 51-60, 61-75, or any combination thereof.

4.8 Any one of compounds 4.1-4.7, wherein X is selected from CH ₂ , -C(O)-, -C(O)- 0-, and -C(0)-N(R)-.

4.9 Any one of compounds 4.1-4.7, wherein X is selected from -S(O)-, -S(0 ₂ )-, - S(0 ₂ )-0-, and -S(0 ₂ )-N(R)-.

4.10 Any one of compounds 4.1-4.7, wherein X is selected from a bond, CH ₂ , -C(O)-, and -C(0)-0-.

4.11 Any one of compounds 4.1-4.7, wherein X is a bond.

4.12 Any one of compounds 4.1-4.11, wherein Y is selected from CH ₂ CH ₂ , -C(O)-, - CH ₂ CH ₂ -C(0)-, and -CH ₂ CH ₂ -C(0)-0-. 4.13 Any one of compounds 4.1-4.11, wherein Y is selected from -S(O)-, and -S(02)-.

4.14 Any one of compounds 4.1-4.11, wherein Y is CH2CH2.

4.15 Any one of compounds 4.1-4.11, wherein Y is -C(O)-.

4.16 Any one of compounds 4.1-4.15, wherein R is H.

4.17 Any one of compounds 4.1-4.15, wherein R is C1-C6 alkyl (e.g., methyl, ethyl, propyl).

4.18 Any one of compounds 4.1-4.15, wherein R is C1-C6 alkyl substituted by one or more OH, e.g., R is selected from hydroxyethyl, hydroxypropyl, hydroxybutyl, hydroxypentyl, and hydroxhexyl.

4.19 Compound 4.18, wherein R is selected from -CH2CH2OH, -CH(OH)CH3, - CH(OH)CH ₂ (OH), -CH2CH2CH2OH, -CH ₂ CH(OH)CH , -CH(OH)CH ₂ CH ₃ , - CH ₂ CH(OH)CH ₂ OH, -CH(OH)CH ₂ CH ₂ OH, -CH(OH)CH(OH)CH ₃ , and - CH(OH)CH(OH)CH ₂ OH.

4.20 Any one of compounds 4.1-4.19, wherein R ³ is selected from H, C1-C20 alkyl, and C2-C20 alkenyl.

4.21 Compound 4.20, wherein R ³ is a C6-18 alkyl, e.g., C6-12 alkyl, C12-18 alkyl, C6-10 alkyl, C 10-14 alkyl, or C14-18 alkyl.

4.22 Compound 4.20, wherein R ³ is a C6-18 alkenyl, e.g., C6-12 alkenyl, C12-18 alkenyl, C6-10 alkenyl, C 10-14 alkenyl, or C14-18 alkenyl, each of which may optionally be monounsaturated or di-unsaturated.

4.23 Compound 4.20, wherein R ³ is a Ci- ₃ alkyl, e.g., CH2 or CH2CH2.

4.24 Any one of compounds 4.1-4.19, wherein R ³ is -C(O)-Ci-C20 alkyl or -C(0)-C ₂ - C20 alkenyl.

4.25 Compound 4.24, wherein R ³ is a -C(0)-C _6-i8 alkyl, e.g., -C(0)-C _6-i2 alkyl, -C(O)- C12-18 alkyl, -C(0)-C _6-i o alkyl, -C(0)-Cio-i4 alkyl, or -C(0)-Ci _4-i8 alkyl.

4.26 Compound 4.24, wherein R ³ is a -C(0)-C _6-i s alkenyl, e.g., -C(0)-C _6-i2 alkenyl, - C(0)-Ci2-i8 alkenyl, -C(0)-C6-io alkenyl, -C(0)-Cio-i4 alkenyl, or -C(0)-Ci _4-i s alkenyl, each of which may optionally be monounsaturated or di-unsaturated.

4.27 Any one of compounds 4.1-4.19, wherein R ³ is -(CH ₂ CH ₂ 0) _m -CH ₂ CH ₂ 0H, wherein m is an integer from 1-75, e.g., 1-25, 25-50, 50-75, 25-75, 1-10, 11-20, 21-30, 31-40, 41-50, 51-60, 61-75, or any combination thereof. 4.28 Any one of compounds 4.1-4.19, wherein R ³ is selected from -(CFhCFhOV- CH2CH2O-C1-C20 alkyl, -(CH ₂ CH2O) _m -CH2CH ₂ O-C2-C20 alkenyl, -(CH ₂ CH ₂ 0) _m - CH ₂ CH ₂ 0-C(0)-CI-C _2O alkyl, and -(CH2CH ₂ O) _m -CH2CH ₂ O-C(O)-C2-C20 alkenyl.

4.29 Compound 4.28, wherein m is an integer from 1-75, e.g., 1-25, 25-50, 50-75, 25- 75, 1-10, 11-20, 21-30, 31-40, 41-50, 51-60, 61-75, or any combination thereof.

4.30 Compound 4.28 or 4.29, wherein said C1-C20 alkyl is a C6-18 alkyl, e.g., C6-12 alkyl, C12-18 alkyl, C6-10 alkyl, C 10-14 alkyl, or C14-18 alkyl.

4.31 Compound 4.28 or 4.29, wherein said C2-C20 alkenyl is a C6-18 alkenyl, e.g., C6-12 alkenyl, C12-18 alkenyl, C6-10 alkenyl, Cio-14 alkenyl, or C14-18 alkenyl.

4.32 Any one of compounds 4.1-4.19, wherein R ³ is:

4.33 Any one of compounds 4.1-4.19, wherein R ³ is: , wherein

X, Y, n and m are as defined in any of 4.1-4.19.

4.34 Any one of compounds 4.1-4.19, wherein R ³ is -CH2CH2OH, -CH2CH(CH3)OH, - CH2COOH, -CH2CH2COOH, -S(0) ₂ -0H, or -P(0) ₂ (0H).

4.35 Any preceding compound, wherein:

X is a bond, and Y is CH2CH2; or X is a bond, and Y is -C(O)-; or

X is a bond, and Y is - CfhCfh-CXO)-; or X is a bond, and Y is -S(0) ₂ -.

4.36 Compound 4.35, wherein R ³ is H.

4.37 Compound 4.35, wherein R ³ is -CH2CH2OH, -CH ₂ CH(CH ₃ )OH, - CH2COOH, - CH2CH2COOH, -S(0) ₂ -0H, or -P(0) ₂ (0H).

4.38 Compound 4.35, wherein the compound is the compound of Formula II-A and wherein R ³ is: , wherein X, Y and m are as defined for the compound of Formula II-A (i.e., all values of X, Y and m are the same in the compound).

4.39 Compound 4.34, wherein the compound is the compound of Formula II-B and wherein R ³ is: , wherein

X, Y, n, and m are as defined for the compound of Formula II-A (i.e., all values of X, Y, n, and m are the same in the compound).

4.40 Any preceding compound which comprises any group -COOH, -S(0) ₂ -0H, or - P(0) ₂ (0H), wherein said group is in the form of a salt, e.g., an alkali metal salt (e.g., lithium, sodium or potassium salt), or an alkaline earth metal salt (e.g., magnesium or calcium salt).

4.41 Any preceding compound which comprises any basic amine group (e.g., -NFh), wherein said group is in the form of an acid addition salt, e.g., a salt with strong Bronsted acid (e.g., hydrochloride, sulfate, phosphate salt).

4.42 Any preceding compound wherein the terminal groups of the compound of Formula II-A or II-B are each: g/

4.43 Any preceding compound wherein the terminal groups l! of the compound of Formula II-A or II-B are each:

[00021] The term “alkyl” as used herein refers to a monovalent or bivalent, branched or unbranched saturated hydrocarbon group having from 1 to 20 carbon atoms, typically although, not necessarily, containing 1 to about 12 carbon atoms, such as methyl, ethyl, n-propyl, isopropyl, n-butyl, isobutyl, t-butyl, octyl, and the like. The term alkyl also may include cycloalkyl groups. Thus, for example, the term C6 alkyl would embrace cyclohexyl groups, the term C5 would embrace cyclopentyl groups, the term C4 would embrace cyclobutyl groups, and the term C3 would embrace cyclopropyl groups. In addition, as the alkyl group may be branched or unbranched, any alkyl group of n carbon atoms would embrace a cycloalkyl group of less than n carbons substituted by additional alkyl substituents. Thus, for example, the term C6 alkyl would also embrace methylcyclopentyl groups, or dimethylcyclobutyl or ethylcyclobutyl groups, or trimethylcyclopropyl, ethylmethylcyclopropyl or propylcyclopropyl groups.

[00022] The term “alkenyl” as used herein refers to a monovalent or bivalent, branched or unbranched, unsaturated hydrocarbon group typically although not necessarily containing 2 to about 12 carbon atoms and 1 -10 carbon-carbon double bonds, such as ethylene, n-propylene, isopropylene, n-butylene, isobutylene, t-butylene, octylene, and the like. In like manner as for the term “alkyl”, the term “alkenyl” also embraces cycloalkenyl groups, both branched an unbranched with the double bond optionally intracyclic or exocyclic.

[00023] The term “aryl” as used herein refers to an aromatic hydrocarbon moiety comprising at least one aromatic ring of 5-6 carbon atoms, including, for example, an aromatic hydrocarbon having two fused rings and 10 carbon atoms (i.e., a naphthalene).

[00024] By “substituted” as in “substituted alkyl,” “substituted alkenyl,” “substituted alkynyl,” and the like, it is meant that in the alkyl, alkenyl, alkynyl, or other moiety, at least one hydrogen atom bound to a carbon atom is replaced with one or more non-hydrogen substituents, e.g., by a functional group.

[00025] The terms “branched” and “linear” (or “unbranched”) when used in reference to, for example, an alkyl moiety of C _a to C _b carbon atoms, applies to those carbon atoms defining the alkyl moiety. For example, for a C4 alkyl moiety, a branched embodiment thereof would include an isobutyl, whereas an unbranched embodiment thereof would be an n-butyl. However, an isobutyl would also qualify as a linear C3 alkyl moiety (a propyl) itself substituted by a Ci alkyl (a methyl).

[00026] Unless otherwise specified, any carbon atom with an open valence may be further substituted by one or more additional functional groups. Examples of functional groups include, without limitation: halo, hydroxyl, sulfhydryl, C1-C20 alkoxy, C2-C20 alkenyloxy, C2-C20 alkynyloxy, C5-C20 aryloxy, acyl (including C2-C20 alkylcarbonyl (-CO-alkyl) and C6-C20 arylcarbonyl (-CO-aryl)), acyloxy (-O-acyl), C2-C20 alkoxycarbonyl (-(CO)-O-alkyl), C6-C20 aryloxycarbonyl (-(CO)-O-aryl), halocarbonyl (-CO)-X where X is halo), C2-C20 alkylcarbonato (-O-(CO)-O-alkyl), C6-C20 arylcarbonato (-O-(CO)-O-aryl), carboxy (-COOH), carboxylato (- COO ^" ), carbamoyl (-(CO)-NH2), mono-substituted C1-C20 alkylcarbamoyl (-(CO)-NH(Ci-C20 alkyl)), di-substituted alkylcarbamoyl (-(CO)-N(Ci-C20 alkyl)2), mono-substituted arylcarbamoyl (-(CO)-NH-aryl), thiocarbamoyl (-(CS)-NH ₂ ), carbamido (-NH-(CO)-NH ₂ ), cyano (-CºN), isocyano (-N ⁺ ºC ^" ), cyanato (-0-CºN), isocyanato (-0-N ⁺ ºC ^" ), isothiocyanato (- S-CºN), azido (-N=N ⁺ =N ^" ), formyl (-(CO)-H), thioformyl (-(CS)-H), amino (-NH ₂ ), mono- and di-(Ci-C ₂₀ alkyl)-substituted amino, mono- and di-(Cs-C ₂₀ aryl)-substituted amino, C ₂ -C ₂₀ alkylamido (-NH-(CO)-alkyl), C ₅ -C ₂₀ arylamido (-NH-(CO)-aryl), imino (-CR=NH where R = hydrogen, Ci-C20 alkyl, C ₅ -C ₂₀ aryl, C ₆ -C ₂₀ alkaryl, C ₆ -C ₂₀ aralkyl, etc.), alkylimino (- CR=N(alkyl), where R = hydrogen, alkyl, aryl, alkaryl, etc.), arylimino (-CR=N(aryl), where R = hydrogen, alkyl, aryl, alkaryl, etc.), nitro (-NO ₂ ), nitroso (-NO), sulfo (-SO ₂ -OH), sulfonato (- SO ₂ -O ^" ), C ₁ -C ₂₀ alkylsulfanyl (-S-alkyl; also termed “alkylthio”), arylsulfanyl (-S-aryl; also termed “arylthiol”), C ₁ -C ₂₀ alkylsulfinyl (-(SO)-alkyl), C ₅ -C ₂₀ arylsulfinyl (-(SO)-aryl), C ₁ -C ₂₀ alkylsulfonyl (-S0 ₂ -alkyl), C ₅ -C ₂₀ arylsulfonyl (-S0 ₂ -aryl), phosphono (-P(0)(0H) ₂ ), phosphonato (-P(0)(0 ^~ ) ₂ ), phosphinato (-P(0)(0 )), phospho (-P0 ₂ ),-phosphino (-PH ₂ ), mono- and di-(Ci-C ₂₀ alkyl)-substituted phosphino, mono- and di-(Cs-C ₂₀ aryl)- substituted phosphino; and the hydrocarbyl moieties such as C ₁ -C ₂₀ alkyl (including Ci-Cis alkyl, further including Ci- C ₁₂ alkyl, and further including C ₁ -C ₆ alkyl), C ₂ -C ₂₀ alkenyl (including C ₂ -C ₁₈ alkenyl, further including C ₂ -C ₁₂ alkenyl, and further including C ₂ -C ₆ alkenyl), C ₂ -C ₂₀ alkynyl (including C ₂ -C ₁₈ alkynyl, further including C ₂ -C ₁₂ alkynyl, and further including C ₂ -C ₆ alkynyl), C ₅ -C ₃₀ aryl (including C ₅ -C ₂₀ aryl, and further including C ₅ -C ₁₂ aryl), and C ₆ -C ₂₀ aralkyl (including C ₆ -C ₂₀ aralkyl, and further including C ₆ -C ₁₂ aralkyl). In addition, the aforementioned functional groups may, if a particular group permits, be further substituted with one or more additional functional groups or with one or more hydrocarbyl moieties such as those specifically enumerated above. For example, the alkyl or alkenyl group may be branched. For example, the “substituent” is an alkyl group, e.g., a methyl group.

[00027] In a second aspect, the present disclosure provides a method of making any compound disclosed herein, e.g., the Compound 1 or Compound 2, et seq., comprising the step of reacting citronellol or a polycitronellol polymer with an alkoxylating agent to yield an alkoxylated derivative, optionally followed by reacting the alkoxylated derivative with one or more suitable reagents to provide the final compound. For example, a compound of Formula I-A may be formed as follows: wherein substituents X, Y, R ¹ and R ² , and m, are as defined hereinabove.

[00028] Suitable reagents, solvents and reactions conditions (concentration, time, temperature) for the conducting the reactions are generally known to those skilled in the art and are not limited in any way in the present disclosure. Depending on the choice of reagents, suitable solvents may include one or more of apolar, polar protic and/or polar aprotic solvents, for example hydrocarbons, ethers, and esters.

[00029] In another aspect, the present disclosure provides a composition comprising Compound 1A or IB or any of 1.1 to 1.42, or Compound 2A or 2B or any of 2.1-2.43, or Compound 3A or 3B or any of 3.1 to 3.42, or Compound 4A or 4B or any of 4.1-4.43, optionally in admixture with one or more pharmaceutically acceptable, cosmetically acceptable, or industrially acceptable excipients or carriers, for example, solvents, oils, surfactants, emollients, diluents, glidants, abrasives, humectants, polymers, plasticizer, catalyst, antioxidant, coloring agent, flavoring agent, fragrance agent, antiperspirant agent, antibacterial agent, antifungal agent, hydrocarbon, stabilizer, or viscosity controlling agent. In some embodiments, the composition is a pharmaceutical composition, or a cosmetic composition, or a sunscreen composition, or a plastic composition, or a lubricant composition, or a personal care composition (e.g., a soap, skin cream or lotion, balm, shampoo, body wash, hydrating cream, deodorant, antiperspirant, aftershave lotion, cologne, perfume, or other hair care or skin care product), or a cleaning composition (e.g., a surface cleaner, a metal cleaner, a wood cleaner, a glass cleaner, a body cleaner such as a soap, a dish-washing detergent, or a laundry detergent), or an air freshener, or a crop-care formulation (e.g., herbicide, insecticide).

[00030] The compounds of the present disclosure, e.g., Compounds 1A, IB, 2A, 2B, 3A, 3B, 4A, 4B, et seq., may be used with, e.g.: perfumes, soaps, insect repellants and insecticides, herbicides, detergents, household cleaning agents, air fresheners, room sprays, pomanders, candles, cosmetics, toilet waters, pre- and aftershave lotions, talcum powders, hair-care products, body deodorants, anti-per spirants, shampoo, cologne, shower gel, hair spray, and pet litter. [00031] Fragrance and ingredients and mixtures of fragrance ingredients that may be used in combination with the disclosed compound for the manufacture of fragrance compositions include, but are not limited to, natural products including extracts, animal products and essential oils, absolutes, resinoids, resins, and concretes, and synthetic fragrance materials which include, but are not limited to, alcohols, aldehydes, ketones, ethers, acids, esters, acetals, phenols, ethers, lactones, furansketals, nitriles, acids, and hydrocarbons, including both saturated and unsaturated compounds and aliphatic carbocyclic and heterocyclic compounds, and animal products.

[00032] In some embodiments, the present disclosure provides personal care compositions including, but not limited to, soaps (liquid or solid), body washes, skin and hair cleansers, skin creams and lotions (e.g., facial creams and lotions, face oils, eye cream, other anti-wrinkle products), ointments, sunscreens, moisturizers, hair shampoos and/or conditioners, deodorants, antiperspirants, other conditioning products for the hair, skin, and nails (e.g., shampoos, conditioners, hair sprays, hair styling gel, hair mousse), decorative cosmetics (e.g., nail polish, eye liner, mascara, lipstick, foundation, concealer, blush, bronzer, eye shadow, lip liner, lip balm,) and dermocosmetics.

[00033] In some embodiments, the personal care compositions may include organically- sourced ingredients, vegan ingredients, gluten-free ingredients, environmen tally-friendly ingredients, natural ingredients (e.g. soy oil, beeswax, rosemary oil, vitamin E, coconut oil, herbal oils etc.), comedogenic ingredients, natural occlusive plant based ingredients (e.g. cocoa, shea, mango butter), non-comedogenic ingredients, bakuchiol (a plant derived compound used as a less-irritating, natural alternative to retinol), color active ingredients (e.g., pigments and dyes); therapeutically-active ingredients (e.g., vitamins, alpha hydroxy acids, corticosteroids, amino acids, collagen, retinoids, antimicrobial compounds), sunscreen ingredients and/or UV absorbing compounds, reflective compounds, oils (such as castor oil and olive oil, or high- viscosity oils), film formers, high molecular weight esters, antiperspirant active ingredients, glycol solutions, water, alcohols, emulsifiers, gellants, emollients, water, polymers, hydrocarbons, conditioning agents, and/or aliphatic esters.

[00034] In some embodiments, the present compositions are gluten free.

[00035] In some embodiments, the present compositions are formulated as oil-in-water emulsions, or as water-in-oil emulsions. In some embodiments, the compositions may further comprise one or more hydrocarbons, such as heptane, octane, nonane, decane, undecane, dodecane, isododecane, tridecane, tetradecane, pentadecane, hexadecane, heptadecane, octadecane, nonadecane, henicosane, docosane, and tricosane, and any saturated linear or saturated branched isomer thereof.

[00036] As used herein, the phrases “for example,” “for instance,” “such as,” or “including” are meant to introduce examples that further clarify more general subject matter. These examples are provided only as an aid for understanding the disclosure, and are not meant to be limiting in any fashion. Furthermore, as used herein, the terms “may,” “optional,” “optionally,” or “may optionally” mean that the subsequently described circumstance may or may not occur, so that the description includes instances where the circumstance occurs and instances where it does not. For example, the phrase “optionally present” means that an object may or may not be present, and, thus, the description includes instances wherein the object is present and instances wherein the object is not present.

[00037] As used herein, the phrase “having the formula” or “having the structure” is not intended to be limiting and is used in the same way that the term “comprising” is commonly used.

[00038] In the present specification, the structural formula of the compounds represents a certain isomer for convenience in some cases, but the present invention includes ail isomers, such as geometrical isomers, optical isomers based on an asymmetrical carbon, stereoisomers, tautomers, and the like. In addition, a crystal polymorphism may be present for the compounds represented by the formulas describe herein. It is noted that any crystal form, crystal form mixture, or anhydride or hydrate thereof is included in the scope of the present invention.

[00039] “Tautomers” refers to compounds whose structures differ markedly in arrangement of atoms, but which exist in easy and rapid equilibrium. It is to be understood that the compounds of the invention may be depicted as different tautomers, it should also be understood that when compounds have tautomeric forms, ail tautomeric forms are intended to be within the scope of the invention, and the naming of the compounds does not exclude any tautomeric form. Further, even though one tautomer may be described, the present invention includes all tautomers of the present compounds.

[00040] As used herein, the term “salt” can include acid addition salts including hydrochlorides, hydrobromides, phosphates, sulfates, hydrogen sulfates, alkylsulfonates, arylsulfonates, acetates, benzoates, citrates, maleates, fumarates, succinates, lactates, and tartrates; alkali metal cations such as Na+, K+, Li+, alkali earth metal salts such as Mg2+ or Ca2+, or organic amine salts, or organic phosphonium salts.

[00041] All percentages used herein, unless otherwise indicated, are by volume.

[00042] All ratios used herein, unless otherwise indicated, are by molarity.

EXAMPLES

[00043] The preparation of polycitronellol polymers, and some derivatives thereof, is described in, e.g., US 2017/0283553, US 2020/0165383, US 2021/0230364, WO 2021/133994, WO 2021/146461, WO 2021/146448, and WO 2021/178217, the contents of each of which are hereby incorporated by reference in their entireties.

[00044] The compounds disclosed herein can be prepared through a number of straightforward chemical reactions. In the following exemplary schemes, the moiety “A” may represent either citronellol or polycitronellol, each in either saturated or unsaturated form:

1- (i) CIS O2CH2CH2OTB S , Et ₃ N, DCM; (ii) TBAF, THF

2- (i) C1C(0)CH ₂ CH ₂ 0TBS, Et ₃ N, DCM; (ii) TBAF, THF 3- Ethylene oxide, KOH, MTBE

4- CH ₃ 0C(0)CH ₂ CH ₂ C1, KOMe, DCM

5- NaOH, H ₂ 0, THF

6- (i) HOOCH(OMOM)CH(OMOM)CH ₂ OMOM, DCC, DMAP, THF; (ii) TFA, DCM

7- (i) C1(CH ₂ ) _I3 C(0)0CH ₃ , Et ₃ N, DCM; (ii) NaOH, H ₂ 0, THF; (iii) HOCH ₂ CH ₂ NH ₂ , AcN

[00045] Other compounds within the scope of the present disclosure can be made by similar methods.